Nanolive label-free live cell
imaging and analysis

A revolution for cell biology

Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics

Nanolive delivers breakthrough label-free live cell imaging and analysis solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.

Nanolive’s label-free live cell imaging and analysis platforms allow scientists to explore living cells in 3D without damaging them. By delivering complete measurements and understandings on a sub-cellular scale (e.g. mitochondrial networks, stem cell differentiation), Nanolive technology allows screening across thousands of live cell populations, and potential therapeutic use of those same, unperturbed, cells.

Application fields such as drug discovery, immuno-oncology, mitochondria & cell metabolism, neuroscience

Groundbreaking technology (platforms & consumables)

Swiss high precision and quality

Over 300 units installed worldwide

Award-winning technology

Patented product & technology

12’000 ft² headquarters in Switzerland with an international Team in USA & Europe

More than 1’000 citations in scientific papers

A deep understanding of live cells and their dynamics

Nanolive’s label-free live cell imaging and analysis platforms, consumables and services are built on technology that is 100% non-invasive, thus circumventing the use of current end-point assays that damage cells.

This allows live cells to be imaged and analyzed for an unlimited amount of time while characterizing their dynamics with the most reliable and quantitative results.

Our solutions are accelerating the drug discovery and development workflows of leading biopharma companies, transforming immuno-oncology, pathway discovery, mitochondrial & cell metabolism analysis, and sensitive cell line analytics. We are applying our technology to new research areas such as cell therapy manufacturing, regenerative medicine QA/QC and biotechnology.